Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 22, 2006Cancer Research

Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells

View Full Paper
Ask AI
Bookmark
Share

Authors

MCMichael F. ClarkeStanford University
John E. Dick
John E. DickUniversity of Toronto
PDPeter B. DirksHospital for Sick Children

Discussion

Loading...

Member takes

Implication

Expert workshop evaluates cancer stem cell models in tumor progression, highlighting the role of self-renewing cellular subsets in driving malignancy.

Key Points

  • To review emerging evidence surrounding the cancer stem cell model and assess how self-renewing cellular subpopulations drive tumor initiation and progression.
  • Convened an expert workshop organized by the American Association for Cancer Research (AACR).
  • Evaluated preclinical and clinical data regarding small subsets of cancer cells displaying stem-like self-renewal properties.
  • Identified that cancer development and progression can be driven by distinct cellular subsets possessing self-renewal capacities analogous to normal stem cells.
  • Highlighted the necessity of characterizing cancer stem cell biology to guide novel therapeutic strategies targeting tumor propagation.

Cite This Study

Clarke et al. (2006) studied this question.

synapsesocial.com/papers/6a0cb356c63d985fc0886193https://doi.org/10.1158/0008-5472.can-06-3126
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Stem Cells in Solid Tumors: Accumulated Evidence and Future Directions2024
  2. 2Targeting cancer stem cells: advances in small molecules, biologics, and immunotherapies2026
  3. 3Cancer stem cells in cholangiocarcinoma: emerging roles as therapeutic targets2025
  4. 4Comprehensive Review of Methods for Cancer Stem Cell Identification and Characterization2025 · 1 citations
  5. 5The resilient subset: cancer stem cells at the core of immunotherapy resistance2025